Sign Up Today and Learn More About Sun Genomics Stock
Invest in or calculate the value of your shares in Sun Genomics or other pre-IPO companies through EquityZen's platform.
Sun Genomics Stock (SUGE)
Sun Genomics provides personalized probiotic solutions based on AI and whole-genome sequencing of the microbiome.
About Sun Genomics Stock
Founded
2016
Headquarters
San Diego, CA, US
Industries
Science and Engineering, Health Care, Food and Beverage
Sun Genomics Press Mentions
Stay in the know about the latest news on Sun Genomics
The Best of San Diego 2024: Health & Fitness
sandiegomagazine • Jun 26, 2024
I Tried It: Custom Floré Probiotics to Heal My Gut
sandiegomagazine • Jun 25, 2024
Natural Products Industry News Briefs: Natural Grocers, Sabinsa, & More
wholefoodsmagazine • Jun 25, 2024
Floré Clinical Teams Up With Evexia Diagnostics
naturalpractitionermag • Jun 25, 2024
Floré Clinical makes personalized microbiome mapping tech more accessible to clinicians
nutraingredients-usa • Jun 25, 2024
Sun Genomics Management
Leadership team at Sun Genomics
Founder and CEO
Sunny Jain
Series A Director
Janelle Goulard
Join now and verify your accreditation status to gain access to:
- Sun Genomics current valuation
- Sun Genomics stock price
- Available deals in Sun Genomics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Sun Genomics Stock
How to invest in Sun Genomics stock?
Accredited investors can buy pre-IPO stock in companies like Sun Genomics through EquityZen funds. These investments are made available by existing Sun Genomics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Sun Genomics stock?
Shareholders can sell their Sun Genomics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
